Single-Use, Fixed-Bed Bioreactors




The scale-X™ is a single-use fixed-bed bioreactor portfolio for automated, scalable bioprocessing of viral vaccines and vectors. A novel spiral-wound fixed-bed structure enables high cell density in a small footprint (volume) with homogeneous distribution and ultra-low shear media circulation. Users can scale processes seamlessly across the portfolio with various diameters (hydro, carbo, nitro) offering production capacity from bench to batch. The single-use, automated bioreactor systems allow for intensified cell culture and viral production from pilot to large scale industrial manufacturing (2.4 m² to 600 m² and above), offering the opportunity to supply the gene therapy market with the required quantities in an affordable manner.

This site uses Akismet to reduce spam. Learn how your comment data is processed.